Anthropic, the AI startup valued at $1.5 trillion, is simultaneously fighting for founder control of its upcoming public listing and defending itself against a Pentagon‑imposed supply‑chain risk designation. The dual fronts highlight the growing tension between corporate governance strategies and national‑security scrutiny in the fast‑moving AI sector.
What happened
Anthropic’s seven co‑founders, including CEO Dario Amodei, have asked shareholders to approve a new share structure that would grant them a combined 50.1 % voting majority on most corporate matters. The proposal, reported by The Information and covered by TechCrunch, relies on special “super‑voting” shares that carry no extra economic value but give the founders decisive control as long as at least three of them retain a minimum stake. Each founder currently owns roughly 2 % of the company and has pledged to give away 80 % of their wealth, a commitment announced by Amodei earlier this year to address concerns about AI‑driven wealth concentration.
The voting plan also expands the founders’ board representation from two seats to three, while Anthropic’s Long‑Term Benefit Trust would continue to select most of the board. Employees would receive their own stock to break ties on certain issues. The move mirrors past founder‑control tactics used by Mark Zuckerberg at Meta and Evan Spiegel at Snap, but Anthropic’s approach is notable for its collective nature.
At the same time, a federal appeals court in Washington, D.C., upheld the Department of Defense’s (DoD) designation of Anthropic as a supply‑chain risk. The Pentagon had blacklisted the company in March after negotiations over the deployment of its Claude models on the military’s GenAI.mil platform broke down. The court’s 2‑1 decision rejected Anthropic’s claim that the ban was arbitrary, unauthorized, and unconstitutional, affirming that the DoD had sufficient justification to view the integration of Claude into defense systems as a national‑security risk.
The ruling prevents the U.S. military and its contractors from using Anthropic’s models. Anthropic, which signed a $200 million contract with the Pentagon in July 2025, had sought assurances that its technology would not be used for fully autonomous weapons or domestic mass surveillance—terms the DoD did not accept. The company continues to explore legal avenues, including a possible rehearing, an en banc petition, or a Supreme Court appeal.
Why it matters
The voting‑control proposal underscores a broader debate about how AI firms can balance founder vision with public‑market accountability. By securing a slim majority, the Anthropic founders aim to steer the company’s long‑term strategy, particularly around ethical commitments such as wealth redistribution and responsible AI deployment. Their approach could set a precedent for other high‑valuation AI startups that wish to retain mission‑driven leadership after going public.
The court’s affirmation of the Pentagon’s blacklist adds a layer of regulatory risk for AI firms seeking government contracts. The decision signals that the DoD is willing to wield supply‑chain designations to limit the use of powerful generative models it deems risky. For Anthropic, the ruling not only blocks a lucrative defense market but also raises questions about how AI companies negotiate terms that protect both national security and their own ethical standards.
Together, these developments illustrate the tightrope AI companies walk between attracting massive private capital—Anthropic was valued at $965 billion in May and $1.5 trillion on the secondary market—and navigating governmental scrutiny that can directly affect product deployment and revenue streams.
The bigger picture
Anthropic’s actions occur against a backdrop of increasing scrutiny of AI’s societal impact. The founders’ pledge to give away most of their wealth reflects a growing awareness that AI‑generated fortunes could exacerbate inequality. Their push for super‑voting shares mirrors a pattern among tech founders who seek to preserve strategic direction while tapping public markets.
Simultaneously, the Pentagon’s supply‑chain risk designation is part of a broader effort by the U.S. government to assess and mitigate AI‑related national‑security threats. The DoD’s stance follows similar moves by other agencies that have placed restrictions on foreign and domestic AI technologies deemed potentially harmful. Anthropic’s legal battle highlights the complex interplay between commercial AI development, defense procurement, and policy frameworks that are still evolving.
The case also surfaces the political dimension of AI governance. Former President Trump has publicly criticized Anthropic’s CEO, Dario Amodei, and the company’s calls for an industry‑wide slowdown.
What happens next
Anthropic’s shareholders will vote on the proposed super‑voting structure in the coming days, a decision that will shape the company’s governance post‑IPO. If approved, the founders will retain a controlling voice despite owning a modest equity stake.
Legally, Anthropic has indicated it remains “confident in our position” and is considering further review. The appeals court delayed the immediate effect of its decision, giving the company time to petition for a rehearing, seek an en banc review, or potentially bring the case before the Supreme Court. The outcome of these efforts will determine whether the Pentagon’s blacklist stays in force or is overturned.
Both fronts—corporate governance and regulatory challenge—are likely to influence investor sentiment ahead of Anthropic’s public offering. The market will be watching how the company balances founder control, ethical commitments, and compliance with national‑security directives as it navigates the next phase of growth.
